Eun-Ju Lee

11PUBLICATIONS
16CO-AUTHORS
Pharmaceutical delivery technologiesPharmacogenomicsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)HaematologyHealth economics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jun 20, 2023
A phase 3, randomized, double-blind, active-controlled trial evaluating efficacy and safety of avatrombopag versus eltrombopag in ITP.

Michael D Tarantino, James B Bussel, Eun-Ju Lee

|Jun 06, 2023
Plasma gastric biomarker evaluation with avatrombopag dosing in patients with chronic immune thrombocytopenia in phase 3 trials.

James B Bussel, Michael D Tarantino, Eun-Ju Lee

|Apr 22, 2023
Maintenence rituximab following induction in autoimmune cytopenias.

Manoj P Rai, Eun-Ju Lee, James B Bussel

|Apr 13, 2022
Rilzabrutinib, an Oral BTK Inhibitor, in Immune Thrombocytopenia.

David J Kuter, Merlin Efraim, Jiri Mayer

|Oct 07, 2021
TPO versus TPO: the good, the bad, and the to be determined.

Eun-Ju Lee, Hanny Al-Samkari

|Sep 29, 2021
SARS-CoV-2 vaccination and ITP in patients with de novo or preexisting ITP.

Eun-Ju Lee, Marina Beltrami-Moreira, Hanny Al-Samkari

Pageof 2